Humacyte To Present Phase 3 Results Comparing Efficacy And Safety Of Tissue-Engineered Vessel To AV Fistulas In End-Stage Renal Disease Patients At VEITH Symposium On November 23, 2024
Humacyte To Present Phase 3 Results Comparing Efficacy And Safety Of Tissue-Engineered Vessel To AV Fistulas In End-Stage Renal Disease Patients At VEITH Symposium On November 23, 2024
Humacyte将在2024年11月23日的VEITH研讨会上展示对比组织工程血管与动静脉瘘在终末期肾病患者中疗效和安全性的第三阶段结果。
Humacyte To Present Phase 3 Results Comparing Efficacy And Safety Of Tissue-Engineered Vessel To AV Fistulas In End-Stage Renal Disease Patients At VEITH Symposium On November 23, 2024
Humacyte将在2024年11月23日的VEITH研讨会上展示对比组织工程血管与动静脉瘘在终末期肾病患者中疗效和安全性的第三阶段结果。